Sanofi inks deal with I-Mab; Wave discloses $175M offering on heels of DMD data

Plus, news about BioAge, Ful­crum Ther­a­peu­tics and Ar­cutis Bio­ther­a­peu­tics:

Sanofi snags Greater Chi­na rights to CD73 an­ti­body: The French phar­ma

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.